{"result": "(\"entity\"<|>CORTICOIDES<|>EVENT<|>Corticosteroids are a class of steroid hormones used in the treatment of adrenal insufficiency and other medical conditions.)\n##\n(\"entity\"<|>HIDROCORTISONA<|>EVENT<|>Hydrocortisone is a corticosteroid medication used to treat adrenal insufficiency, administered intravenously or intramuscularly.)\n##\n(\"entity\"<|>SUERO SALINO FISIOLÓGICO<|>EVENT<|>Physiological saline solution is used in medical treatments, particularly in cases of hypovolemic shock.)\n##\n(\"entity\"<|>SUERO GLUCOSADO<|>EVENT<|>Glucose saline solution is administered to prevent hypoglycemia in patients undergoing treatment for adrenal crises.)\n##\n(\"entity\"<|>ANÁLISIS REALIZADOS<|>EVENT<|>Refers to the tests and analyses conducted to diagnose conditions such as adrenal insufficiency.)\n##\n(\"entity\"<|>TUMOR PRODUCTOR DE CATECOLAMINAS<|>EVENT<|>A type of tumor that produces catecholamines, which can lead to various medical conditions, including adrenal crises.)\n##\n(\"entity\"<|>INTERVENCIÓN QUIRÚRGICA<|>EVENT<|>Surgical intervention is performed to treat conditions such as tumors affecting the adrenal glands.)\n##\n(\"relationship\"<|>INSUFICIENCIA SUPRARRENAL<|>CORTICOIDES<|>Corticosteroids are essential in the treatment of adrenal insufficiency<|>9)\n##\n(\"relationship\"<|>HIDROCORTISONA<|>INSUFICIENCIA SUPRARRENAL<|>Hydrocortisone is a primary treatment for adrenal insufficiency<|>9)\n##\n(\"relationship\"<|>SUERO SALINO FISIOLÓGICO<|>INSUFICIENCIA SUPRARRENAL<|>Physiological saline solution is administered to patients in shock due to adrenal insufficiency<|>6)\n##\n(\"relationship\"<|>SUERO GLUCOSADO<|>INSUFICIENCIA SUPRARRENAL<|>Glucose saline solution is often given to prevent hypoglycemia in adrenal crisis patients<|>6)\n##\n(\"relationship\"<|>ANÁLISIS REALIZADOS<|>INSUFICIENCIA SUPRARRENAL<|>The analyses performed are crucial for diagnosing adrenal insufficiency<|>7)\n##\n(\"relationship\"<|>TUMOR PRODUCTOR DE CATECOLAMINAS<|>INSUFICIENCIA SUPRARRENAL<|>Tumors producing catecholamines can lead to adrenal crises and require careful management<|>5)\n##\n(\"relationship\"<|>INTERVENCIÓN QUIRÚRGICA<|>TUMOR PRODUCTOR DE CATECOLAMINAS<|>Surgical intervention is necessary for the treatment of catecholamine-producing tumors<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 17% de los pacientes\n               excepto:                                                                                                                                  presentan eosinofilia.\n               A. Fracaso renal agudo.                                                                                                                   La insuficiencia suprarrenal aguda es una emergencia médica que pone en riesgo la vida\n               B. Hipocalcemia.                                                                                                                          del paciente, y su tratamiento no debe demorarse por esperar a la realización de pruebas\n                                                                                                                                                         diagnósticas definitivas.          No obstante, además de la determinación de los electrolitos en\n               C. Eosinofilia.                                                                                                                           plasma y de la glucemia, deben obtenerse las muestras adecuadas para determinar ACTH\n               D.  Hiponatremia e hiperpotasemia.                                                                                                        y cortisol antes de iniciar el tratamiento con corticoides.\n                                                                                                                                                         Se debe administrar hidrocortisona por vía intravenosa en dosis de 100 mg cada 6-8 horas.\n                                                                                                                                                         Si no es posible, se debe utilizar la vía intramuscular. En el paciente en shock hipovolémico\n                                                                                                                                                         se debe administrar 1 litro de suero salino fisiológico por vía intravenosa durante la prime-\n\n\n\n302                                                                                                                                                                                                                                                            303\n---\n                                                                                                                                                                                                                         SUPRARRENALES                5\n\n\n\n              ra hora. Debido a la posibilidad de hipoglucemia, es habitual administrar suero glucosado                                         52  Tras el diagnóstico de localización, el paciente es intervenido quirúrgicamente con\n              al 5%. El tratamiento posterior con suero fisiológico o con suero glucosado o glucosalino                                             resultado de tumor productor de catecolaminas, infiltrativo localmente. Señale la\n              dependerá de la monitorización bioquímica y del estado del paciente. Si el diagnóstico es                                             respuesta correcta en relación con este tipo de tumores:\n              correcto, debe observarse una mejoría clínica, especialmente en la tensión arterial, en las                                           A. El fenotipo bioquímico no es útil como guía del estudio genético.\n              primeras 4 a 6 horas. Es importante reconocer y tratar cualquier afección asociada, como\n              una infección, que puede haber precipitado la crisis suprarrenal aguda.                                                               B. El fenotipo bioquímico con secreción predominante de adrenalina suele estar presente\n              Después de las primeras 24 horas, se puede reducir la dosis de hidrocortisona, por lo gene-                                               en pacientes con mutaciones del gen RET y del gen VHL.\n              ral a 50 mg por vía i.m. o i.v. cada 6 horas y después, si el paciente puede tomarla por vía                                          C. La determinación de cromogranina A plasmática es una prueba altamente específica\n              oral, a hidrocortisona oral, 40 mg por la mañana y 20 mg por la tarde. A continuación, se                                                 para el diagnóstico de tumores productores de catecolaminas.\n              podrá reducir a una dosis sustitutiva de 20 mg al día, dividida en dos o tres fracciones al día.                                      D.  El fenotipo bioquímico con secreción predominante de noradrelina suele estar presente\n                                                                                                                                                        en pacientes con mutaciones del gen VHL y de SDHx.\n              Referencias:\n              • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds.             En el estudio histológico del tumor, el resultado de la inmunohistoquímica muestra\n                Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.                    53\n              • Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal            SDHB negativo. ¿Qué estudio realizaría en primer lugar?\n                insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:364-89.\n              • De Miguel Novoa P. Insuficiencia adrenal primaria. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es      A. Estudio del gen RET.\n                (última modificación: 25 de noviembre de 2015).\n              • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook       B. Estudio del gen SDHB.\n                of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n                                                                                                                                                    C. Estudio del gen VHL.\n                                                                                                                                                    D.  Estudio del gen SDHC.\n     5.8 Casos clínicos. Caso clínico 2\n                                                                                                                                                54  El estudio genético fue positivo. Respecto al seguimiento de este paciente y sus\n                                                                                                                                                    familiares, señale la respuesta correcta:\n       50     Teniendo en cuenta el resultado de los análisis realizados\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>A medical textbook edited by Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, and Loscazo J, providing principles of internal medicine.)\n##\n(\"entity\"<|>ENDOCRINE SOCIETY<|>ORGANIZATION<|>A professional organization that provides clinical practice guidelines for the diagnosis and treatment of endocrine disorders.)\n##\n(\"entity\"<|>MÉXICO DF<|>GEO<|>The capital city of Mexico, where the 19th edition of the medical textbook was published.)\n##\n(\"entity\"<|>GEN RET<|>EVENT<|>A genetic study related to mutations that may be present in patients with certain tumors.)\n##\n(\"entity\"<|>GEN SDHB<|>EVENT<|>A genetic study related to mutations that may be present in patients with certain tumors.)\n##\n(\"entity\"<|>GEN VHL<|>EVENT<|>A genetic study related to mutations that may be present in patients with certain tumors.)\n##\n(\"entity\"<|>GEN SDHC<|>EVENT<|>A genetic study related to mutations that may be present in patients with certain tumors.)\n##\n(\"entity\"<|>INSUFICIENCIA SUPRARRENAL<|>EVENT<|>A medical condition characterized by the failure of the adrenal glands to produce sufficient hormones, requiring immediate treatment.)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ENDOCRINE SOCIETY<|>The Endocrine Society provides clinical practice guidelines referenced in the Harrison textbook<|>7)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>INSUFICIENCIA SUPRARRENAL<|>The Endocrine Society provides guidelines for the diagnosis and treatment of adrenal insufficiency<|>8)\n##\n(\"relationship\"<|>GEN RET<|>INSUFICIENCIA SUPRARRENAL<|>The study of the RET gene is relevant for understanding certain tumors associated with adrenal insufficiency<|>5)\n##\n(\"relationship\"<|>GEN SDHB<|>INSUFICIENCIA SUPRARRENAL<|>The study of the SDHB gene is relevant for understanding certain tumors associated with adrenal insufficiency<|>5)\n##\n(\"relationship\"<|>GEN VHL<|>INSUFICIENCIA SUPRARRENAL<|>The study of the VHL gene is relevant for understanding certain tumors associated with adrenal insufficiency<|>5)\n##\n(\"relationship\"<|>GEN SDHC<|>INSUFICIENCIA SUPRARRENAL<|>The study of the SDHC gene is relevant for understanding certain tumors associated with adrenal insufficiency<|>5)\n<|COMPLETE|>"}]}